These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats. Jansen H; Baggen RG J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S16-20. PubMed ID: 2447435 [TBL] [Abstract][Full Text] [Related]
9. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension. Pool JL; Taylor AA; Nelson EB Am J Med; 1989 Aug; 87(2A):57S-61S. PubMed ID: 2569825 [TBL] [Abstract][Full Text] [Related]
10. Interactions of doxazosin with insulin or glucagon in the ob/ob mouse. Swindell AC; Valentine JJ J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S20-4; discussion S24. PubMed ID: 2471011 [TBL] [Abstract][Full Text] [Related]
11. Studies of serum lipids in hypercholesterolaemic rabbits treated with doxazosin. Leren TP; Berg K Scand J Clin Lab Invest; 1988 Jun; 48(4):313-7. PubMed ID: 2907180 [TBL] [Abstract][Full Text] [Related]
12. Studies with doxazosin on the saturable binding of 125I-LDL by liver in normocholesterolemic mice. Nanjee MN; Miller NE J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S35-41. PubMed ID: 2447439 [TBL] [Abstract][Full Text] [Related]
13. Effects of alpha 1-inhibition on lipid metabolism in the rat. Woodside WF; Swindell AC J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S27-34. PubMed ID: 2447438 [TBL] [Abstract][Full Text] [Related]
14. Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model. Foxall TL; Shwaery GT; Stucchi AF; Nicolosi RJ; Wong SS Am J Pathol; 1992 Jun; 140(6):1357-63. PubMed ID: 1351367 [TBL] [Abstract][Full Text] [Related]
15. Effect of doxazosin on plasma lipids and atherogenesis: a preliminary report. Kowala MC; Nicolosi RJ J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S45-9; discussion S49. PubMed ID: 2471015 [TBL] [Abstract][Full Text] [Related]
16. Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension. Pool JL Am J Cardiol; 1987 May; 59(14):46G-50G. PubMed ID: 2884853 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacotherapeutics of doxazosin. Taylor SH Am J Med; 1989 Aug; 87(2A):2S-11S. PubMed ID: 2569822 [TBL] [Abstract][Full Text] [Related]